Justin A Renz

CIK 1466562 · CFO · last filed 2026-03-19

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.51M

Companies

4

Total Filings

45

Lifetime Open-Market Net

-$1.69M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ZVRA CFO $12.65 $0 1 2026-03-19
ARDX Chief Financial Officer 409,052 $5.69 $2.33M -$1.80M 30 2025-08-25
KPTI EVP, CFO & Treasurer 19,173 $9.50 $182.1K $113.0K 8 2017-01-24
EPIRUS Biopharmaceuticals, Inc. (CRXX) Delisted SVP & CFO $0 2 2010-01-20

Recent Filings · Page 2 of 5

45 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-12-28 ARDX Mixed −150,000 -$1.36M EDGAR
2023-11-22 ARDX Sell (S) −2,873 -$12.5K EDGAR
2023-08-23 ARDX Sell (S) −2,884 -$10.2K EDGAR
2023-05-25 ARDX Sell (S) −2,873 -$10.5K EDGAR
2023-02-24 ARDX Sell (S) −3,439 -$10.3K EDGAR
2023-01-06 ARDX Grant (A) +78,000 $0 EDGAR
2022-11-23 ARDX Sell (S) −1,504 -$2.9K EDGAR
2022-09-01 ARDX Buy (P) +3,000 $1.9K EDGAR
2022-08-24 ARDX Sell (S) −1,498 -$1.5K EDGAR
2022-06-08 ARDX Sell (S) −73,312 -$47.7K EDGAR
Showing 1120 of 45
Page 2 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.